Critical Care Devices Market Size, Share, and Trends 2024 to 2033

Critical Care Devices Market (By Product: Ventilators, Cardiac Monitors, Infusion Pumps, Hemodynamic Monitors, Defibrillators, Intracranial Pressure Monitors, Patient Warmers, Anesthesia Machines, Continuous Renal Replacement Therapy Machines, Electrocardiography Machines; By Application: Cardiology, Neurology, Respiratory Therapy, Trauma Surgery, Renal Care, Neonatology, Oncology Critical Care; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : March 2024
  • Report Code : 3935
  • Category : Healthcare

Critical Care Devices Market Size and Manufacturers

The global critical care devices market size was estimated at USD 57.93 billion in 2023 and is anticipated to reach around USD 95.17 billion by 2033 with a CAGR of 5.09% from 2024 to 2033. Advanced critical care devices enhance patient monitoring, providing real-time data for swift intervention, improving patient outcomes, and reducing medical errors in intensive care settings.

Critical Care Devices Market Size 2024 to 2033

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Key Takeaways

  • North America led the most significant share of the critical care devices market in 2023.
  • Asia Pacific is projected to expand at the fastest rate during the forecast period of 2024-2033.
  • By product, the ventilators segment held the largest share of the market in 2023.
  • By product, the continuous renal replacement therapy (CRRT) Machines segment is expected to show the fastest growth.
  • By application field, the cardiology segment held the dominating share of the market in 2023.
  • By application field, the renal care segment shows notable growth in the critical care devices market during the forecast period.
  • By end-user, the hospitals segment held the dominating share of the market in 2023.
  • By end-user, the home healthcare settings segment is expected to witness a significant rate of expansion during the forecast period.

Critical Care Devices Market Overview

Critical care devices are medical instruments designed to monitor and support patients with life-threatening conditions or those in intensive care units (ICUs). These devices encompass a wide range of devices tailored to various critical care needs, including monitoring vital signs, administering medications, and providing life-sustaining therapies. Common critical care devices include ventilators for respiratory support, cardiac monitors for tracking heart activity, infusion pumps for delivering precise medication doses, and hemodynamic monitors for assessing blood circulation. Additionally, devices like defibrillators for cardiac emergencies and intracranial pressure monitors for neurological conditions are vital components of critical care settings.

The application of critical care devices is essential across various medical specialties, including emergency medicine, cardiology, neurology, and critical care medicine. These devices play a crucial role in stabilizing patients during emergencies, managing complex medical conditions, and optimizing patient outcomes in ICU settings. Overall, critical care devices serve as indispensable tools for healthcare professionals, enabling them to monitor patients’ conditions closely, administer appropriate treatments, and provide life-saving interventions in critical situations. Their continued advancements contribute to improving patient care and enhancing medical outcomes in critical care settings.

Growth Factors

  • Advancements in technology led to the development of more sophisticated devices capable of providing comprehensive patient monitoring and treatment options. These innovations include advanced ventilators with integrated monitoring systems, hemodynamic monitoring devices with improved accuracy, and infusion pumps with enhanced safety features.
  • The increasing prevalence of chronic diseases and the aging population contributed to the rising demand for the critical care devices market. Conditions such as respiratory disorders, cardiovascular diseases, and neurological disorders necessitate intensive monitoring and therapeutic interventions, driving the adoption of specialized devices in critical care settings.
  • The growing emphasis on patient safety and quality of care prompted healthcare facilities to invest in state-of-the-art critical care equipment. Hospitals and clinics prioritize devices that offer reliability, accuracy, and ease of use to ensure optimal patient outcomes and streamline clinical workflows.
  • Regulatory initiatives aimed at improving patient outcomes and reducing healthcare-associated infections played a significant role in shaping the critical care devices market landscape. Compliance with stringent regulations and standards drove manufacturers to innovate and develop devices with enhanced infection control measures and patient safety features.
  • The COVID-19 pandemic underscored the importance of critical care devices in managing respiratory failure and other complications associated with severe illness. The increased demand for ventilators, oxygen therapy equipment, and patient monitoring devices further fueled the growth of the critical care devices market as healthcare systems worldwide bolstered their critical care capacities to address the pandemic's challenges.

Critical Care Devices Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 5.09%
Global Market Size in 2023 USD 57.93 Billion
Global Market Size by 2033 USD 95.17 Billion
Largest Market North America
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Product, By Application, and By End-user
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa


Critical Care Devices Market Dynamics

Drivers

Rising incidence of chronic diseases

The increasing prevalence of chronic conditions such as cardiovascular diseases, respiratory disorders, and neurological ailments drives the demand for critical care devices. As these conditions often require intensive monitoring and treatment, healthcare facilities invest in advanced devices like ventilators, cardiac monitors, and intracranial pressure monitors to provide optimal care to patients, propelling the growth of the critical care devices market.

  • In November 2023, BioIntelliSense partnered with UC Davis Health to debut a Continuous Monitoring Program for Bone Marrow Transplant Patients. Leveraging FDA-cleared BioButton® wearables and advanced analytics, clinicians gain invaluable health insights, aiding in the management of transplant patients for early detection of clinical deterioration.

Technological advancements and innovation

Ongoing technological advancements, including the integration of artificial intelligence, wireless connectivity, and remote monitoring capabilities, continually enhance the performance and functionality of critical care devices. These innovations improve patient outcomes, streamline workflow efficiency, and reduce healthcare costs, compelling healthcare providers to invest in upgrading their critical care infrastructure, thereby fueling the expansion of the critical care devices market.

  • In June 2023, Pune-based medical technology company Noccarc unveiled the groundbreaking Noccarc V730i Smart ICU Ventilator, ushering in a new era of intelligent critical care. Developed by expert engineers and medical professionals, this state-of-the-art ventilator sets new industry standards with its connectivity, safety features, and cloud capabilities.
  • In October 2023, Ceribell, Inc.® launched ClarityPro™ AI, enhancing diagnosis of electrographic status epilepticus. The algorithm enables swift and precise detection and monitoring of critically ill patients. With potential reimbursement for eligible Medicare recipients, ClarityPro™ expands access to crucial diagnostic tools in healthcare.
  • In December 2023, Technimount EMS introduced the Bracket Pro Serie 60 – GR2 and FL, catering to the demands of the industry for increased flexibility and safety in EMS and critical care transport. Technimount’s solutions enhance efficiency and security in medical transportation.

Restraints

High initial investment costs

One significant restraint in the adoption of critical care devices is the high initial investment costs associated with purchasing and implementing these advanced medical devices. The sophisticated technology and specialized features incorporated into critical care devices often result in substantial upfront expenses for healthcare facilities. These costs encompass not only the purchase price of the equipment but also installation, training, maintenance, and potential upgrades over time.

Due to budget constraints and financial limitations, many healthcare institutions may find it challenging to afford the upfront investment required to procure critical care equipment in the critical care devices market. Additionally, smaller healthcare facilities or those in resource-limited settings may face even greater barriers in acquiring these expensive devices. Consequently, the high initial investment costs serve as a significant deterrent to the widespread adoption of critical care equipment, hindering accessibility to advanced critical care technologies and potentially impacting patient care outcomes.

Opportunities

Remote monitoring integration

One opportunity lies in the integration of remote monitoring capabilities into the critical care devices market. Advancements in telemedicine and remote patient monitoring technologies present an opportunity to enhance critical care delivery by allowing healthcare professionals to monitor patients’ vital signs and device parameters from a distance.

Future critical care devices could incorporate features such as wireless connectivity and cloud-based data storage, enabling real-time transmission of patient data to healthcare providers. This remote monitoring capability would facilitate early detection of clinical deterioration, timely intervention, and improved patient outcomes, particularly in scenarios where on-site medical expertise is limited or when managing patients in remote or underserved areas.

Personalized medicine integration

Another opportunity lies in the integration of personalized medicine approaches into critical care devices. With advances in genomics, pharmacogenomics, and precision medicine, there is growing recognition of the importance of tailoring medical treatments to individual patient characteristics. Future critical care equipment could leverage patient-specific data, such as genetic profiles, biomarkers, and responses to therapies, to optimize treatment strategies and improve clinical outcomes.

This personalized approach could involve the development of smart algorithms and decision support systems within critical care devices to assist healthcare providers in selecting the most effective interventions for each patient based on their unique physiological and genetic makeup. By incorporating personalized medicine principles, future critical care equipment has the potential to revolutionize patient care by delivering more targeted and efficient treatments, ultimately leading to better outcomes and reduced healthcare costs.

Products Insights

The ventilators segment held the largest share of the critical care devices market in 2023. With the recent COVID-19 pandemic, ventilators have been in high demand for providing respiratory support to patients with severe cases of the virus. These critical care devices deliver oxygen to the lungs and help patients breathe when they are unable to do so on their own. The advanced features of modern ventilators, such as adjustable parameters and modes tailored to different patient needs, make them essential in managing respiratory distress and improving patient outcomes.

The continuous renal replacement therapy (CRRT) machines segment is expected to show the fastest growth in the critical care devices market during the forecast period. CRRT machines have seen increased use in critical care settings for patients with acute kidney injury or severe renal dysfunction. These machines perform continuous removal of waste products and excess fluids from the blood, mimicking the function of the kidneys. They are vital in maintaining fluid and electrolyte balance, managing metabolic imbalances, and preventing complications in critically ill patients with compromised renal function.

Application Insights

The cardiology devices segment dominated the critical care devices market in 2023. Cardiology remains a dominant field due to the close relationship between renal function and cardiovascular health. Many cardiac patients suffer from comorbidities such as hypertension and heart failure, which can significantly impact renal function. Cardiologists closely monitor renal function in these patients as part of comprehensive cardiac care, often requiring frequent assessments and interventions to manage renal complications.

The renal care segment shows notable growth in the critical care devices market during the forecast period. Unsurprisingly, renal care stands out as another dominant segment for renal function applications. This field is specifically focused on managing kidney health and treating conditions such as chronic kidney disease (CKD) and acute kidney injury (AKI). Renal care facilities heavily rely on renal function assessments to diagnose and monitor kidney diseases, adjust treatment regimens, and optimize patient outcomes. Given the increasing prevalence of kidney-related disorders globally, the demand for renal care and associated critical care devices continues to rise steadily.

End-user Insights

The hospitals segment dominated the critical care devices market in 2023. Hospitals remain the primary users of critical care, offering comprehensive medical services and accommodating patients with various critical conditions. They require a wide range of equipment, including ventilators, cardiac monitors, and infusion pumps, to support intensive care units (ICUs) and emergency departments.

The home healthcare settings segment is expected to witness notable growth in the critical care devices market during the forecast period. With the increasing trend towards home-based care, critical care devices are increasingly utilized in home healthcare settings. Devices like portable ventilators, oxygen concentrators, and vital signs monitors enable patients to receive critical care services in the comfort of their homes, promoting patient comfort and reducing healthcare costs.

Regional Insights

North America led the biggest share of the critical care devices market in 2023. North America’s dominance reflects its advanced healthcare infrastructure, high healthcare spending, and robust research and development capabilities. The region boasts a large number of established medical device manufacturers and leading healthcare institutions, driving innovation and adoption of advanced critical care technologies. Moreover, factors such as an aging population, high prevalence of chronic diseases, and stringent regulatory standards contribute to the strong demand for critical care devices in North America.

Critical Care Devices Market Share, By Region, 2023 (%)

Asia-Pacific is expected to witness growth at a significant rate in the critical care devices market during the forecast period of 2024-2033. The emergence of Asia Pacific as an important market signifies shifting global healthcare dynamics. Rapid economic growth, increasing healthcare investments, and expanding healthcare access in countries like China, India, and Japan are driving the demand for critical care devices. Additionally, rising healthcare awareness, growing middle-class populations, and increasing government initiatives to improve healthcare infrastructure are fueling market growth in the region.

Recent Developments

  • In August 2023, Medanta, in collaboration with GE HealthCare, launched the Medanta e-ICU Command Centre, offering round-the-clock remote care for ICU patients. This innovative service provides advanced consultation, care, and near-real-time monitoring of critically ill individuals, eliminating the need for physical transfers to specialized hospitals.
  • In May 2023, medical device maker Poly Medicure plans to introduce a local and indigenous dialysis machine, part of India's Make in India initiative. Himanshu Baid, MD, revealed that the machine, currently in the trial phase, will have over 50% domestic content. Initial production aims at 200 units, with scaling based on demand.

Critical Care Devices Market Companies

  • Skanray Technologies Pvt. Ltd.
  • Air Liquide Medical Systems India
  • Asahi Kasei Corporation
  • Ventec Life Systems
  • Vyaire Medical
  • ICU Medical Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Drägerwerk AG & Co. KGaA
  • Koninklijke Philips N.V.
  • Cardinal Health Inc.
  • Airon Corporation
  • Becton, Dickinson, and Co.
  • OSI Systems Inc.
  • Biometrix Ltd.
  • General Electric Co.
  • Teleflex Incorporated
  • Bunnell Incorporated
  • Getinge AB
  • Breas Medical AB
  • Q-core Medical Ltd.
  • Boston Scientific Corporation
  • Baxter International Inc.
  • Hamilton Medical
  • Smith’s Medical Inc.
  • ResMed Inc.
  • B. Braun Melsungen AG
  • Avanos Medical Inc.
  • Medtronic plc

Segments Covered in the Report

By Product

  • Ventilators
  • Cardiac Monitors
  • Infusion Pumps
  • Hemodynamic Monitors
  • Defibrillators
  • Intracranial Pressure Monitors
  • Patient Warmers
  • Anesthesia Machines
  • Continuous Renal Replacement Therapy (CRRT) Machines
  • Electrocardiography (ECG/EKG) Machines

By Application

  • Cardiology
  • Neurology
  • Respiratory Therapy
  • Trauma Surgery
  • Renal Care
  • Neonatology
  • Oncology Critical Care

By End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Long-Term Care Facilities
  • Home Healthcare Settings

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

The global critical care devices market size is expected to increase USD 95.17 billion by 2033 from USD 57.93 billion in 2023.

The global critical care devices market will register growth rate of 5.09% between 2024 and 2033.

The major players operating in the critical care devices market are Skanray Technologies Pvt. Ltd., Air Liquide Medical Systems India, Asahi Kasei Corporation, Ventec Life Systems, Vyaire Medical, ICU Medical Inc., Fresenius Medical Care AG & Co. KGaA, Drägerwerk AG & Co. KGaA, Koninklijke Philips N.V., Cardinal Health Inc., Airon Corporation, Becton, Dickinson, and Co., OSI Systems Inc., Biometrix Ltd., General Electric Co., Teleflex Incorporated, Bunnell Incorporated, Getinge AB, and Others.

The driving factors of the critical care devices market are the rising incidence of chronic diseases and technological advancements and innovation.

North America region will lead the global critical care devices market during the forecast period 2024 to 2033.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Critical Care Devices Market 

5.1. COVID-19 Landscape: Critical Care Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Critical Care Devices Market, By Product

8.1. Critical Care Devices Market Revenue and Volume, by Product, 2024-2033

8.1.1 Ventilators

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Cardiac Monitors

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Infusion Pumps

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Hemodynamic Monitors

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

8.1.5. Defibrillators

8.1.5.1. Market Revenue and Volume Forecast (2021-2033)

8.1.6. Intracranial Pressure Monitors

8.1.6.1. Market Revenue and Volume Forecast (2021-2033)

8.1.7. Patient Warmers

8.1.7.1. Market Revenue and Volume Forecast (2021-2033)

8.1.8. Anesthesia Machines

8.1.8.1. Market Revenue and Volume Forecast (2021-2033)

8.1.9. Continuous Renal Replacement Therapy (CRRT) Machines

8.1.9.1. Market Revenue and Volume Forecast (2021-2033)

8.1.10. Electrocardiography (ECG/EKG) Machines

8.1.10.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Critical Care Devices Market, By Application

9.1. Critical Care Devices Market Revenue and Volume, by Application, 2024-2033

9.1.1. Cardiology

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Neurology

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Respiratory Therapy

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

9.1.4. Trauma Surgery

9.1.4.1. Market Revenue and Volume Forecast (2021-2033)

9.1.5. Renal Care

9.1.5.1. Market Revenue and Volume Forecast (2021-2033)

9.1.6. Neonatology

9.1.6.1. Market Revenue and Volume Forecast (2021-2033)

9.1.7. Oncology Critical Care

9.1.7.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Critical Care Devices Market, By End-user 

10.1. Critical Care Devices Market Revenue and Volume, by End-user, 2024-2033

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Ambulatory Surgical Centers

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. Specialty Clinics

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

10.1.4. Long-Term Care Facilities

10.1.4.1. Market Revenue and Volume Forecast (2021-2033)

10.1.5. Home Healthcare Settings

10.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Critical Care Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.1.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.1.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.1.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.1.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.1.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.1.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.6.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.7.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.6.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.7.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.6.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.7.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.5.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.5.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

11.5.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.5.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

Chapter 12. Company Profiles

12.1. Skanray Technologies Pvt. Ltd.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Air Liquide Medical Systems India

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Asahi Kasei Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Ventec Life Systems

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Vyaire Medical

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. ICU Medical Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Fresenius Medical Care AG & Co. KGaA

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Drägerwerk AG & Co. KGaA

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Koninklijke Philips N.V.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Cardinal Health Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client